Earnshaw SR, Moride Y, Moshyk A, Rochon S. Cost-effectiveness of macugen compared to photodynamic therapy (PDT) with verteporfin and standard care in the treatment of subfoveal wet age-related macular degeneration (AMD) in the elderly in Canada. Poster presented at the Third Annual Canadian Joint Therapeutics Congress, Canadian Association for Population Therapeutics; May 13, 2006. Toronto, Canada.
Javitt JC, Earnshaw SR, Graham CN, Brogan AJ, Zlateva GP, Pleil AM. Cost-effectiveness of Macugen versus no treatment in age-related macular degeneration patients. Poster presented at the Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting; April 2006.
Rubino A, Wang J, Davis KL, Tzivelekis S, Rousculp MD, Girach A, Tesfaye S. Severity of diagnosed diabetic retinopathy in the UK primary Cary. Poster presented at the Annual Professional Conference of Diabetes UK; March 30, 2006.
Javitt JC, Zlateva GP, Earnshaw SR, Pleil AM, Graham CN, Brogan AJ. Cost-effectiveness model for age-related macular degeneration: comparing Macugen® to Visudyne®. Poster presented at the 2006 World Ophthalmology Congress; February 2006. Previously presented at the ISPOR 8th Annual European Congress.
Earnshaw SR, Javitt JC, Zlateva GP, Pleil AM, Graham CN, Brogan AJ, Shah S, Adamis AP. Cost-effectiveness model for age-related macular degeneration: comparing Macugen® to Visudyne®. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 10, 2005. Florence, Italy.
Earnshaw SR, Javitt JC, Graham CN, Brogan AJ, Zlateva GP, Shah S, Adamis AP. Modeling treatments for subfoveal choroidal neovascularization secondary to age-related macular degeneration: cost-effectiveness methods. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 10, 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A179.
Earnshaw SR, Javitt JC, Zlateva GP, Pleil AM, Graham CN, Brogan AJ, Shah S, Adamis AP. Cost-effectiveness model for age-related macular degeneration: comparing early and late Macugen® treatment. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 10, 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6).
Candrilli SD, Davis KL, Kan H, Lucero MA, Covington M. Burden of illness associated with symptoms of diabetic peripheral neuropathy and diabetic retinopathy. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 18, 2005. [abstract] Value Health. 2005 May; 8(3):357.
Nicholls TJ, Carpenter BG, Rogers DJ, Cook DJ, Wolowacz SE, Smart JD. An investigationn of lectin binding sites on unfixed corneal and conjunctival surfaces of rats. Poster presented at the Proceedings of IinterLec; 2004.
Hill AR, Aspinall P, Armbrecht A, Lumsden C, Nelson P, Brice R, Vickers AD. Utilities for quality of life from time trade-off and conjoint analysis in age-related macular degeneration. Poster presented at the Heriott Watt University; 2004.
Nicholls TJ, Cook DJ, Rogers DJ, Wolowacz SE, Smart JD. An investigation of lectin toxicity with cultured human conjunctival epithelial cells; lectins: biology biochemistry. Clin Chem. 1996;11:273-6.
Nicholls TJ, Green KL, Cook DJ, Rogers DJ, Wolowacz SE, Smart JD. An investigation of lectins for use in ophthalmic drug delivery. Int J Pharm. 1996;138(2):175-83.
Nicholls TJ, Cook DJ, Rogers DJ, Wolowacz SE, Smart JD. An investigation of lectin binding sites within the precorneal region. J Pharm Pharmacol. 1994;46:1050.
Nicholls TJ, Cook JD, Rogers DJ, Wolowacz SE, Smart JD. The effect of exposure time and washing on the binding of two lectins to tissues from the precorneal region of rats. Poster presented at the British Pharmaceutical Society; 1994.
Astier P, Arana A, Oterino D, Lopez MA, Piero S. Cost analysis for the different strategies in cataract surgery. Presented at the V Congreso de la Sociedad Española de Salud Pública y Administración Sanitaria; 1993. Granada, Spain.
Wolowacz SE, Hamid O, Jones D, Lazare R. Ocular bioavailability of topical triamterene in the conscious rabbit by a non-invasive method. Poster presented at the British Toxicology Society meeting; April 1992. York, United Kingdom.